Skin Analytics
The company develops DERM, a Class III CE marked AI medical device designed to identify skin cancer from images. The platform triages patients by identifying non-cancerous lesions to reduce the burden on specialist dermatologists. Its primary customers are NHS secondary care organizations and primary care providers seeking to manage urgent suspected cancer referral pathways.
Healthtech
Artificial Intelligence
Medical Devices
Funding summary
- Total raised
- €22.0M
- Funding rounds
- 2
Investors in Skin Analytics
Investors on record for Skin Analytics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Skin Analytics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors